Tarceva and Phenytoin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tarceva (erlotinib hydrochloride) and Phenytoin (phenytoin). Common drug interactions include acne among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Tarceva and Phenytoin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

What is Phenytoin?

Phenytoin has active ingredients of phenytoin. It is often used in epilepsy. eHealthMe is studying from 15,753 Phenytoin users. Check the latest studies of Phenytoin.



On Jul, 31, 2026

13 people who take Tarceva and Phenytoin together, and have interactions are studied.

Tarceva and Phenytoin drug interactions.

What are the common drug interactions of Tarceva and Phenytoin, by gender? *:

female:

  1. Acne (skin problems that cause pimples)
  2. Oedema peripheral (superficial swelling)
  3. Anticonvulsant drug level increased
  4. Ataxia (loss of full control of bodily movements)
  5. Balance disorder
  6. Dizziness
  7. Drug level below therapeutic
  8. Dysarthria (speech disorder)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Malignant neoplasm progression (cancer tumour came back)

male:

  1. Pyrexia (fever)
  2. Rash
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Asthenia (weakness)
  5. Asthma
  6. Blood creatinine increased
  7. Blood urea increased
  8. Bronchial carcinoma (lung cancer)
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Decreased appetite

What are the common drug interactions of Tarceva and Phenytoin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anticonvulsant drug level increased
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Pyrexia (fever)
  4. Rash
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Ataxia (loss of full control of bodily movements)
  7. Balance disorder
  8. Dizziness
  9. Drug level below therapeutic
  10. Dysarthria (speech disorder)

60+:

  1. Oedema peripheral (superficial swelling)
  2. Acne (skin problems that cause pimples)
  3. Asthenia (weakness)
  4. Asthma
  5. Blood creatinine increased
  6. Blood urea increased
  7. Bronchial carcinoma (lung cancer)
  8. Cerebral infarction (less blood supply to brain resulting tissue damage)
  9. Decreased appetite
  10. Depressed level of consciousness

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 38.46%
  2. Metastases To Central Nervous System (cancer spreads to central nervous system): 2 people, 15.38%
  3. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 15.38%
  4. Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 15.38%
  5. Thyroid Diseases: 1 person, 7.69%
  6. Swelling: 1 person, 7.69%
  7. Rectal Cancer Metastatic (cancer of rectum spreads to other): 1 person, 7.69%
  8. Pain: 1 person, 7.69%
  9. Neoplasm Malignant (cancer tumour): 1 person, 7.69%
  10. Lung Adenocarcinoma Metastatic (a form of non-small cell lung cancer spreads to other part): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tarceva and Phenytoin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tarceva and Phenytoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenytoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarceva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenytoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on erlotinib hydrochloride and phenytoin (the active ingredients of Tarceva and Phenytoin, respectively), and Tarceva and Phenytoin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: